Different gastric mucosa and CagA status of patients in India and Japan infected with helicobacter pylori

Digestive Diseases and Sciences

Volumn 59, Issue 3, 2014, Pages 631-637

  Fujiya, Keiichi ^a   Nagata, Naoyoshi ^a   Uchida, Tomohisa ^b   Kobayakawa, Masao ^a   Asayama, Naoki ^a   Akiyama, Junichi ^a   Shimbo, Takuro ^a   Igari, Toru ^a   Banerjee, Rupa ^c   Reddy, D Nageshwar ^c   Mizokami, Masashi ^d   Uemura, Naomi ^d  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b OITA UNIVERSITY   (Japan)

^c ASIAN INSTITUTE OF GASTROENTEROLOGY   (India)

^d National Center for Global Health and Medicine   (Japan)

Author keywords

East Asian CagA; Endoscopy; Gastric cancer risk; H. pylori associated gastritis; Updated Sydney System

Indexed keywords

CAGA PROTEIN; EOSIN; HEMATOXYLIN;

ADULT; ARTICLE; ATROPHY; BACTERIAL VIRULENCE; CANCER RISK; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTRITIS; GASTROSCOPY; GIEMSA STAIN; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIA; INTESTINE METAPLASIA; JAPAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFLUX ESOPHAGITIS; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCOSA;

ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; BIOPSY; CROSS-SECTIONAL STUDIES; FEMALE; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INDIA; JAPAN; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84896720100     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2961-x     Document Type: Article

References (30)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:870-873.
2. Roder DM. The epidemiology of gastric cancer. Gastric Cancer. 2002;5:5-11.
3. Fock KM, Ang TL. Epidemiology of helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol. 2010;25: 479-486.
4. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-789.
5. Graham DY, Yamaoka Y. Disease-specific helicobacter pylori virulence factors: The unfulfilled promise. Helicobacter. 2000;5: S3-S9; (discussion S27-S31).
6. Joossens JV, Hill MJ, Elliott P, et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European cancer prevention (ECP) and the INTERSALT cooperative research group. Int J Epidemiol. 1996;25:494-504.
7. Matsuhisa TM, Yamada NY, Kato SK, Matsukura NM. Helicobacter pylori infection, mucosal atrophy and intestinal metaplasia in Asian populations: A comparative study in age-, gender-and endoscopic diagnosis-matched subjects. Helicobacter. 2003;8: 29-35.
8. Lee I, Lee H, Kim M, et al. Ethnic difference of helicobacter pylori gastritis: Korean and Japanese gastritis is characterized by male-and antrum-predominant acute foveolitis in comparison with American gastritis. World J Gastroenterol. 2005;11:94-98.
9. Naylor GM, Gotoda T, Dixon M, et al. Why does japan have a high incidence of gastric cancer? Comparison of gastritis between UK and japanese patients. Gut. 2006;55:1545-1552.
10. Jonaitis L, Ivanauskas A, Janciauskas D, et al. Precancerous gastric conditions in high helicobacter pylori prevalence areas: Comparison between eastern European (lithuanian, latvian) and asian (taiwanese) patients. Medicina (Kaunas). 2007;43:623-629.
11. Abdullah M, Ohtsuka H, Rani AA, Sato T, Syam AF, Fujino MA. Helicobacter pylori infection and gastropathy: A comparison between Indonesian and Japanese patients. World J Gastroenterol. 2009;15:4928-4931.
12. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-1181.
13. Hatakeyama M. Helicobacter pylori and gastric carcinogenesis. J Gastroenterol. 2009;44:239-248.
14. Uchida T, Kanada R, Tsukamoto Y, et al. Immunohistochemical diagnosis of the cagA-gene genotype of helicobacter pyloriwith antieast Asian CagA-specific antibody. Cancer Sci. 2007;98:521-528.
15. Nguyen LT, Uchida T, Kuroda A, et al. Evaluation of the antieast Asian CagA-specific antibody for CagA phenotyping. Clin Vaccine Immunol. 2009;16:1687-1692.
16. Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol. 2005;36:228-233.
17. Wong BC, Ching CK, Lam SK, et al. Differential north to south gastric cancer-duodenal ulcer gradient in China. China ulcer study group. J Gastroenterol Hepatol. 1998;13:1050-1057.
18. Yeomans ND, Naesdal J. Systematic review: Ulcer definition in NSAID ulcer prevention trials. Aliment Pharmacol Ther. 2008; 27:465-472.
19. Kimura K, Takemoto T. Endoscopic atrophy border. Endoscopy. 1969;1:1-3.
20. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet. 1975;2:58-60.
21. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut. 2002;50:378-381.
22. Matsuhisa T, Matsukura N, Yamada N. Topography of chronic active gastritis in helicobacter pylori-positive Asian populations: Age-, gender-, and endoscopic diagnosis-matched study. J Gastroenterol. 2004;39:324-328.
23. Yamaoka Y. Pathogenesis of helicobacter pylori-related gastroduodenal diseases from molecular epidemiological studies. Gastroenterol Res Pract. 2012;2012:371503.
24. Yamaoka Y, Orito E, Mizokami M, et al. Helicobacter pylori in north and South America before columbus. FEBS Lett. 2002;517: 180-184.
25. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2010;7:629-641.
26. Azuma T. Helicobacter pylori CagA protein variation associated with gastric cancer in Asia. J Gastroenterol. 2004;39:97-103.
27. Satoh K. Does eradication of helicobacter pylori reverse atrophic gastritis or intestinal metaplasia? Data from japan. Gastroenterol Clin North Am. 2000;29:829-835.
28. Li GQ, Xia HH, Chen MH, et al. Effects of aspirin on the development of helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in mongolian gerbils. Helicobacter. 2008;13:20-29.
29. Barkin J. The relation between helicobacter pylori and nonsteroidal anti-inflammatory drugs. Am J Med. 1998;105: 22S-27S.
30. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996;334:1018-1022.